USPTO serial 79251242
DBV TECHNOLOGIES
Reviewed by CopyMark Law Group
Reg. 5809654Status 707Registered
- Filing date
- Status date
- Registration date
- Jul 23, 2019
- Examiner
- RIEPEL, CHRISTINA MAXINE
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with DBV TECHNOLOGIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anthony E. Bennett
Anthony E. Bennett Hoffmann & Baron, LLP6900 Jericho TurnpikeSyosset, NY 11791United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ adhesive patches enabling cutaneous or epicutaneous administration of powdered medicated or pharmaceutical substances for humans or animals featuring pharmaceutical preparations for treatment of allergies, inflammatory and autoimmune diseases; drug delivery patch containing a preparation in powder form for medical use for the treatment of allergies, inflammatory and autoimmune diseases; medicated occlusive patch enabling the cutaneous absorption of a powdered medicated substance featuring pharmaceutical preparations for treatment of allergies, inflammatory and autoimmune diseases ] | SECTION 71 - CANCELLED | — |
| 010 | medical apparatus, instruments and devices for the cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for humans or animals, namely, drug delivery patches sold without medication; occlusive dispenser for medical use sold without medication; medical instrument using electrostatic properties from a biocompatible support, namely epicutaneous patches sold without medication | ACTIVE | — |
| 042 | research in the field of immunotherapy; design of a scientific method for epicutaneous desensitization via immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; scientific research in the field of processing and treatment of allergies; scientific research in the field of allergy treatment for a treatment to be applied repeatedly to the skin of the patient without prior preparation of the skin, other than simple and light cleaning in order to leave the cell structure of the skin intact, thus avoiding the transfer of the allergen into the blood; drug discovery being scientific research and development of allergens; design of methods for the treatment of allergy-causing by the combination of immune cells from the skin; design of methods for treating allergies via the application of a patch to the unbroken skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact | ACTIVE | — |
| 044 | medical services applying a method for desensitizing by immunotherapy; medical treatment of allergies, inflammatory and autoimmune diseases via allergen administration by placing a patch on the patient's intact skin while preventing the allergen from getting into the blood; medical treatment of allergies, inflammatory and autoimmune diseases using a method for desensitizing by epicutaneous immunotherapy; medical treatment of allergies, inflammatory and autoimmune diseases by epicutaneous immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to combat allergies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DBV TECHNOLOGIES
- Other trademarks owned by DBV TECHNOLOGIES
- Other trademarks owned by DBV TECHNOLOGIES
- Other trademarks owned by DBV TECHNOLOGIES
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DBV TECHNOLOGIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 20, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 20, 2025 | NA15 | SEC. 15 ACKNOWLEDGEMENT - E-MAILED | — |
| Aug 20, 2025 | 15AK | REGISTERED - SEC. 15 ACKNOWLEDGED | — |
| Aug 20, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Aug 20, 2025 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Aug 11, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 22, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jul 22, 2025 | E15R | TEAS SECTION 15 RECEIVED | — |
| Sep 16, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 16, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 16, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 16, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 16, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 16, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 23, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 13, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 15, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 1, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 6, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 15, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 15, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 23, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 23, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 7, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 7, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 17, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 16, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 15, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 14, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 28, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 28, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 20, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 19, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 15, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 11, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 7, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |